R.R.R. Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -69.71%
(FY 2020)
- Profit 62.47%
(FY 2020)
- Ebitda 107.21%
(FY 2020)
- Net Worth 21.07%
(FY 2020)
- Total Assets 24.26%
(FY 2020)
About R.R.R. Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayaraman Narayanaswamy, Arvindh Rajendran, Ramraj Ravichandran, and One other member serve as directors at the Company.
- CIN/LLPIN
U52300TN2011PTC080455
- Company No.
080455
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at R.R.R. Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayaraman Narayanaswamy  | Director | 04-May-2011 | Current |
| Arvindh Rajendran | Additional Director | 01-Oct-2021 | Current |
| Ramraj Ravichandran | Director | 04-May-2011 | Current |
| Ragulan | Director | 04-May-2011 | Current |
Financial Performance of R.R.R. Pharma.
R.R.R. Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 69.71% decrease. The company also saw a substantial improvement in profitability, with a 62.47% increase in profit. The company's net worth Soared by an impressive increase of 21.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.R.R. Pharma?
In 2019, R.R.R. Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Healthtraze Solutions Private LimitedActive 2 years 3 monthsArvindh Rajendran, Ramraj Ravichandran and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at R.R.R. Pharma?
R.R.R. Pharma has a workforce of 36 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.R.R. Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.R.R. Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
